25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Revive Therapeutics Ltd
Buy, Hold or Sell?

Let's analyze Revive Therapeutics Ltd together

I guess you are interested in Revive Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Revive Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Revive Therapeutics Ltd

I send you an email if I find something interesting about Revive Therapeutics Ltd.

Quick analysis of Revive Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Revive Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.03
Expected worth in 1 year
C$0.02
How sure are you?
38.1%

+ What do you gain per year?

Total Gains per Share
C$-0.01
Return On Investment
-56.6%

For what price can you sell your share?

Current Price per Share
C$0.01
Expected price per share
C$0.01 - C$0.02
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Revive Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

C$0.01

Intrinsic Value Per Share

C$0.48 - C$0.59

Total Value Per Share

C$0.51 - C$0.62

2. Growth of Revive Therapeutics Ltd (5 min.)




Is Revive Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$7.1m$8.1m-$857.9k-11.8%

How much money is Revive Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$765.3k-$1.4m$673.4k88.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Revive Therapeutics Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Revive Therapeutics Ltd? (5 min.)

Welcome investor! Revive Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Revive Therapeutics Ltd.

What can you expect buying and holding a share of Revive Therapeutics Ltd?

First you should know what it really means to hold a share of Revive Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Revive Therapeutics Ltd is C$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Revive Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Revive Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.03. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Revive Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-37.8%0.00-21.4%0.00-40.1%-0.01-53.2%-0.01-50.9%
Usd Book Value Change Per Share0.005.8%0.00-10.2%0.00-16.5%0.008.5%0.009.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.005.8%0.00-10.2%0.00-16.5%0.008.5%0.009.4%
Usd Price Per Share0.02-0.03-0.16-0.16-0.15-
Price to Earnings Ratio-1.20--4.31--9.16--8.08--7.69-
Price-to-Total Gains Ratio31.33--8.40--34.61--7.80--7.80-
Price to Book Ratio0.91-1.24-6.68-9.47-9.02-
Price-to-Total Gains Ratio31.33--8.40--34.61--7.80--7.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.007245
Number of shares138026
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (138026 shares)-141.43117.70
Gains per Year (138026 shares)-565.71470.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-566-5760471461
20-1131-11420942932
30-1697-1708014121403
40-2263-2274018831874
50-2829-2840023542345
60-3394-3406028252816
70-3960-3972032963287
80-4526-4538037663758
90-5091-5104042374229
100-5657-5670047084700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%8.013.00.038.1%8.013.00.038.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%8.013.00.038.1%8.013.00.038.1%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Revive Therapeutics Ltd

About Revive Therapeutics Ltd

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-07-21 00:52:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Revive Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Revive Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0%¬†means that¬†$0.00 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Revive Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient Revive Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • -14.2% Return on Assets means that¬†Revive Therapeutics Ltd generated¬†$-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Revive Therapeutics Ltd:

  • The MRQ is -14.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-7.9%-6.4%
TTM-7.9%YOY-12.8%+4.9%
TTM-7.9%5Y-20.3%+12.5%
5Y-20.3%10Y-20.1%-0.2%
1.1.3. Return on Equity

Shows how efficient Revive Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • -19.1% Return on Equity means Revive Therapeutics Ltd generated $-0.19¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Revive Therapeutics Ltd:

  • The MRQ is -19.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.1%TTM-10.5%-8.5%
TTM-10.5%YOY-17.5%+6.9%
TTM-10.5%5Y-27.6%+17.1%
5Y-27.6%10Y-27.2%-0.4%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Revive Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Revive Therapeutics Ltd is operating .

  • Measures how much profit Revive Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%¬†means the company generated $0.00 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Revive Therapeutics Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Revive Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Revive Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Revive Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.40¬†means the company has $0.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.398. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.488. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.398TTM0.488-0.090
TTM0.488YOY0.648-0.160
TTM0.4885Y5.748-5.260
5Y5.74810Y5.766-0.019
1.3.2. Quick Ratio

Measures if Revive Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.00¬†means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.152-0.152
TTM0.152YOY0.616-0.464
TTM0.1525Y5.515-5.363
5Y5.51510Y5.540-0.024
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Revive Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Revive Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Revive Therapeutics Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.25¬†means that Revive Therapeutics Ltd assets are¬†financed with 25.3% credit (debt) and the remaining percentage (100% - 25.3%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.253. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.255. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.253TTM0.255-0.002
TTM0.255YOY0.269-0.014
TTM0.2555Y0.223+0.032
5Y0.22310Y0.220+0.003
1.4.2. Debt to Equity Ratio

Measures if Revive Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 33.9% means that company has $0.34 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Revive Therapeutics Ltd:

  • The MRQ is 0.339. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.343. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.339TTM0.343-0.004
TTM0.343YOY0.369-0.027
TTM0.3435Y0.359-0.017
5Y0.35910Y0.351+0.008
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Revive Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Revive Therapeutics Ltd generates.

  • Above 15 is considered overpriced but¬†always compare¬†Revive Therapeutics Ltd to the¬†Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.20 means the investor is paying $-1.20¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Revive Therapeutics Ltd:

  • The EOD is -0.479. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.197. Based on the earnings, the company is expensive. -2
  • The TTM is -4.311. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.479MRQ-1.197+0.718
MRQ-1.197TTM-4.311+3.114
TTM-4.311YOY-9.156+4.845
TTM-4.3115Y-8.078+3.767
5Y-8.07810Y-7.693-0.385
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Revive Therapeutics Ltd:

  • The EOD is -0.548. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.370. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.686. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.548MRQ-1.370+0.822
MRQ-1.370TTM-4.686+3.316
TTM-4.686YOY-12.378+7.691
TTM-4.6865Y-10.936+6.250
5Y-10.93610Y-10.416-0.521
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Revive Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.91 means the investor is paying $0.91¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Revive Therapeutics Ltd:

  • The EOD is 0.365. Based on the equity, the company is cheap. +2
  • The MRQ is 0.913. Based on the equity, the company is cheap. +2
  • The TTM is 1.238. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.365MRQ0.913-0.548
MRQ0.913TTM1.238-0.325
TTM1.238YOY6.678-5.440
TTM1.2385Y9.466-8.228
5Y9.46610Y9.015+0.451
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Revive Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.001-0.001+277%-0.002+385%0.001-32%0.001-39%
Book Value Per Share--0.0270.028-2%0.031-13%0.033-18%0.032-15%
Current Ratio--0.3980.488-18%0.648-39%5.748-93%5.766-93%
Debt To Asset Ratio--0.2530.255-1%0.269-6%0.223+13%0.220+15%
Debt To Equity Ratio--0.3390.343-1%0.369-8%0.359-6%0.351-4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.005-0.003-44%-0.006+6%-0.007+41%-0.007+35%
Free Cash Flow Per Share---0.005-0.002-45%-0.005+7%-0.005+11%-0.005+8%
Free Cash Flow To Equity Per Share--0.0010.002-42%0.001+4%0.001-20%0.001-20%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.588--------
Intrinsic Value_10Y_min--0.479--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max--0.020--------
Intrinsic Value_3Y_min--0.018--------
Intrinsic Value_5Y_max--0.116--------
Intrinsic Value_5Y_min--0.103--------
Market Cap3584470.080-150%8961175.20012545645.280-29%77514165.480-88%79844071.032-89%76041972.411-88%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.365-150%0.9131.238-26%6.678-86%9.466-90%9.015-90%
Pe Ratio-0.479+60%-1.197-4.311+260%-9.156+665%-8.078+575%-7.693+543%
Price Per Share0.010-150%0.0250.035-29%0.216-88%0.223-89%0.212-88%
Price To Free Cash Flow Ratio-0.548+60%-1.370-4.686+242%-12.378+804%-10.936+698%-10.416+660%
Price To Total Gains Ratio12.532-150%31.330-8.405+127%-34.607+210%-7.796+125%-7.796+125%
Quick Ratio---0.152-100%0.616-100%5.515-100%5.540-100%
Return On Assets---0.142-0.079-45%-0.128-10%-0.203+43%-0.201+41%
Return On Equity---0.191-0.105-45%-0.175-8%-0.276+45%-0.272+42%
Total Gains Per Share--0.001-0.001+277%-0.002+385%0.001-32%0.001-39%
Usd Book Value--7112701.9537292703.072-2%8150650.358-13%8695990.020-18%8329493.528-15%
Usd Book Value Change Per Share--0.001-0.001+277%-0.002+385%0.001-32%0.001-39%
Usd Book Value Per Share--0.0200.020-2%0.023-13%0.024-18%0.023-15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.002-44%-0.004+6%-0.005+41%-0.005+35%
Usd Free Cash Flow---1184958.873-648897.338-45%-1267328.184+7%-1314727.799+11%-1280257.499+8%
Usd Free Cash Flow Per Share---0.003-0.002-45%-0.004+7%-0.004+11%-0.004+8%
Usd Free Cash Flow To Equity Per Share--0.0010.001-42%0.001+4%0.001-20%0.001-20%
Usd Market Cap2596948.573-150%6492371.4329089320.005-29%56159012.890-88%57847029.463-89%55092409.012-88%
Usd Price Per Share0.007-150%0.0180.025-29%0.157-88%0.161-89%0.154-88%
Usd Profit---1356232.122-765391.142-44%-1438840.699+6%-1924763.283+42%-1841765.664+36%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share--0.001-0.001+277%-0.002+385%0.001-32%0.001-39%
 EOD+2 -6MRQTTM+9 -20YOY+17 -125Y+12 -1710Y+12 -17

3.2. Fundamental Score

Let's check the fundamental score of Revive Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.479
Price to Book Ratio (EOD)Between0-10.365
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.398
Debt to Asset Ratio (MRQ)Less than10.253
Debt to Equity Ratio (MRQ)Less than10.339
Return on Equity (MRQ)Greater than0.15-0.191
Return on Assets (MRQ)Greater than0.05-0.142
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Revive Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.777
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.023
OpenGreater thanClose0.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets13,143
Total Liabilities3,325
Total Stockholder Equity9,817
 As reported
Total Liabilities 3,325
Total Stockholder Equity+ 9,817
Total Assets = 13,143

Assets

Total Assets13,143
Total Current Assets1,293
Long-term Assets11,850
Total Current Assets
Cash And Cash Equivalents 1,049
Total Current Assets  (as reported)1,293
Total Current Assets  (calculated)1,049
+/- 243
Long-term Assets
Property Plant Equipment 1
Long Term Investments 126
Intangible Assets 11,723
Long-term Assets  (as reported)11,850
Long-term Assets  (calculated)11,850
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,246
Long-term Liabilities80
Total Stockholder Equity9,817
Total Current Liabilities
Accounts payable 2,543
Total Current Liabilities  (as reported)3,246
Total Current Liabilities  (calculated)2,543
+/- 703
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt62
Long-term Liabilities  (as reported)80
Long-term Liabilities  (calculated)62
+/- 18
Total Stockholder Equity
Total Stockholder Equity (as reported)9,817
Total Stockholder Equity (calculated)0
+/- 9,817
Other
Capital Stock47,500
Common Stock Shares Outstanding 358,447
Net Invested Capital 9,817
Net Working Capital -1,953
Property Plant and Equipment Gross 15



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,642
1,283
1,542
1,256
7,388
8,261
10,081
10,748
32,351
29,806
28,063
22,470
18,435
17,065
14,764
13,845
15,766
14,252
13,780
12,877
13,143
13,14312,87713,78014,25215,76613,84514,76417,06518,43522,47028,06329,80632,35110,74810,0818,2617,3881,2561,5421,2831,642
   > Total Current Assets 
1,609
528
321
115
904
2,158
3,999
4,788
19,315
16,795
15,076
9,511
5,504
4,164
1,894
1,009
2,965
2,352
1,894
991
1,293
1,2939911,8942,3522,9651,0091,8944,1645,5049,51115,07616,79519,3154,7883,9992,1589041153215281,609
       Cash And Cash Equivalents 
830
475
268
45
713
1,381
3,397
4,378
19,024
16,600
14,818
9,299
5,287
3,916
1,586
710
0
2,087
1,592
708
1,049
1,0497081,5922,08707101,5863,9165,2879,29914,81816,60019,0244,3783,3971,38171345268475830
       Short-term Investments 
0
0
0
0
0
100
113
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000011310000000
       Net Receivables 
0
0
4
51
174
178
125
235
194
127
152
119
143
191
147
159
186
0
0
0
0
000018615914719114311915212719423512517817451400
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
50
50
0
0
0
0005050505000000000000000
   > Long-term Assets 
0
0
1,221
1,141
6,485
6,102
6,082
5,960
13,036
13,012
12,986
12,959
12,931
12,901
12,870
12,836
0
11,900
11,887
11,887
11,850
11,85011,88711,88711,900012,83612,87012,90112,93112,95912,98613,01213,0365,9606,0826,1026,4851,1411,22100
       Property Plant Equipment 
5
4
471
4
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
11112222222233333447145
       Long Term Investments 
0
0
750
750
750
250
250
250
250
250
250
250
250
250
250
250
0
163
163
163
126
126163163163025025025025025025025025025025025075075075000
       Intangible Assets 
28
0
0
0
5,363
5,500
5,500
5,500
12,500
12,500
12,500
12,500
12,500
12,500
12,500
12,500
12,500
11,723
11,723
11,723
11,723
11,72311,72311,72311,72312,50012,50012,50012,50012,50012,50012,50012,50012,5005,5005,5005,5005,36300028
       Other Assets 
0
0
0
387
369
349
329
207
284
259
234
207
179
149
118
85
50
0
0
0
0
00005085118149179207234259284207329349369387000
> Total Liabilities 
262
322
882
771
1,353
832
1,213
889
1,011
1,000
3,871
1,414
3,334
4,463
3,725
4,331
3,921
3,599
3,518
3,346
3,325
3,3253,3463,5183,5993,9214,3313,7254,4633,3341,4143,8711,0001,0118891,2138321,353771882322262
   > Total Current Liabilities 
262
322
473
385
978
372
258
459
604
598
3,492
1,062
3,010
4,166
3,456
4,096
3,720
3,436
3,379
3,208
3,246
3,2463,2083,3793,4363,7204,0963,4564,1663,0101,0623,492598604459258372978385473322262
       Short-term Debt 
0
0
0
0
150
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001500000
       Short Long Term Debt 
0
0
0
0
150
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001500000
       Accounts payable 
0
0
314
251
367
210
95
304
405
436
445
848
2,775
3,916
2,636
3,306
3,592
2,662
2,626
2,491
2,543
2,5432,4912,6262,6623,5923,3062,6363,9162,7758484454364053049521036725131400
   > Long-term Liabilities 
0
0
410
386
375
459
455
430
407
402
379
352
324
296
269
236
0
163
140
138
80
80138140163023626929632435237940240743045545937538641000
       Long term Debt Total 
0
0
410
386
375
0
376
354
332
328
303
276
249
220
189
156
122
85
0
0
0
00085122156189220249276303328332354376037538641000
       Other Liabilities 
0
0
0
0
0
64
79
76
75
74
76
76
75
77
80
80
80
0
0
0
0
000080808077757676747576796400000
> Total Stockholder Equity
1,380
961
659
485
6,036
7,429
8,868
9,858
31,340
28,807
24,192
21,056
15,101
12,603
11,039
9,514
11,845
10,653
10,262
9,531
9,817
9,8179,53110,26210,65311,8459,51411,03912,60315,10121,05624,19228,80731,3409,8588,8687,4296,0364856599611,380
   Common Stock
9,342
9,352
9,352
9,352
15,810
19,126
22,929
26,097
40,631
42,430
42,519
42,795
42,910
43,113
43,482
43,482
45,980
45,980
0
0
0
00045,98045,98043,48243,48243,11342,91042,79542,51942,43040,63126,09722,92919,12615,8109,3529,3529,3529,342
   Retained Earnings -63,601-61,729-60,958-47,983-59,375-57,431-55,906-54,247-51,431-45,408-41,310-36,440-27,588-23,320-20,344-16,321-13,273-11,620-11,247-10,939-10,050
   Capital Surplus 
2,087
2,117
2,124
2,323
2,336
3,221
6,150
6,664
6,852
11,391
11,611
12,395
12,395
12,395
12,395
12,395
12,410
12,656
0
0
0
00012,65612,41012,39512,39512,39512,39512,39511,61111,3916,8526,6646,1503,2212,3362,3232,1242,1172,087
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
430
430
430
1,162
1,403
632
417
11,445
11,425
11,371
11,274
11,227
11,341
11,067
11,067
12,831
0
0
0
0
000012,83111,06711,06711,34111,22711,27411,37111,42511,4454176321,4031,1624304304300



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-5,521
Operating Income-6,390-5,521
 
Operating Expense (+$)
Research Development3,583
Selling General Administrative1,942
Selling And Marketing Expenses0
Operating Expense5,5215,525
 
Net Interest Income (+$)
Interest Income69
Interest Expense-44
Other Finance Cost-40
Net Interest Income65
 
Pretax Income (+$)
Operating Income-6,390
Net Interest Income65
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,321-5,525
EBIT - interestExpense = -44
-6,321
-6,277
Interest Expense44
Earnings Before Interest and Taxes (EBIT)0-6,277
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,321
Tax Provision-0
Net Income From Continuing Ops-6,321-6,321
Net Income-6,321
Net Income Applicable To Common Shares-6,321
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-865-65
 

Technical Analysis of Revive Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Revive Therapeutics Ltd. The general trend of Revive Therapeutics Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Revive Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Revive Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.02 < 0.02 < 0.02.

The bearish price targets are: 0.01 > 0.01 > 0.01.

Tweet this
Revive Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Revive Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Revive Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Revive Therapeutics Ltd. The current macd is -0.00212086.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Revive Therapeutics Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Revive Therapeutics Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Revive Therapeutics Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Revive Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRevive Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Revive Therapeutics Ltd. The current adx is 31.09.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Revive Therapeutics Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Revive Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Revive Therapeutics Ltd. The current sar is 0.02.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Revive Therapeutics Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Revive Therapeutics Ltd. The current rsi is 42.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Revive Therapeutics Ltd Daily Relative Strength Index (RSI) ChartRevive Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Revive Therapeutics Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Revive Therapeutics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Revive Therapeutics Ltd Daily Stochastic Oscillator ChartRevive Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Revive Therapeutics Ltd. The current cci is -96.93372898.

Revive Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartRevive Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Revive Therapeutics Ltd. The current cmo is -13.75506837.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Revive Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartRevive Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Revive Therapeutics Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Revive Therapeutics Ltd Daily Williams %R ChartRevive Therapeutics Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Revive Therapeutics Ltd.

Revive Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Revive Therapeutics Ltd. The current atr is 0.00422415.

Revive Therapeutics Ltd Daily Average True Range (ATR) ChartRevive Therapeutics Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Revive Therapeutics Ltd. The current obv is -12,547,946.

Revive Therapeutics Ltd Daily On-Balance Volume (OBV) ChartRevive Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Revive Therapeutics Ltd. The current mfi is 59.35.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Revive Therapeutics Ltd Daily Money Flow Index (MFI) ChartRevive Therapeutics Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Revive Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Revive Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Revive Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.777
Ma 20Greater thanMa 500.012
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.023
OpenGreater thanClose0.010
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Revive Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Revive Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Revive Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Revive Therapeutics Ltd

I send you an email if I find something interesting about Revive Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Revive Therapeutics Ltd.

Receive notifications about Revive Therapeutics Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.